BDNF and depressive symptom measurement: The cellular and molecular alterations underlying anxiety disorders and depression are partially understood, and involve reductions in synaptic densities in the hippocampus, deficits in serotonergic and noradrenergic neurotransmission, and reduced BDNF signaling (McEwen et al., 2012; Blier and El Mansari, 2013).